Drug Detail:Darifenacin (Darifenacin [ dar-e-fen-a-sin ])
Drug Class: Urinary antispasmodics
Drug Detail:Darifenacin (Darifenacin [ dar-e-fen-a-sin ])
Drug Class: Urinary antispasmodics
Initial dose: 7.5 mg orally once a day
Maintenance dose: The dosage may be increased to 15 mg orally once a day as early as 2 weeks after starting therapy
Comments:
Initial dose: 7.5 mg orally once a day
Maintenance dose: The dosage may be increased to 15 mg orally once a day as early as 2 weeks after starting therapy
Comments:
No adjustment recommended.
Mild hepatic impairment (Child Pugh A): No adjustment recommended.
Moderate hepatic impairment (Child Pugh B): Do exceed 7.5 mg daily.
Severe hepatic impairment (Child Pugh C): Not recommended.
Do not exceed 7.5 mg daily when coadministered with potent CYP450 3A4 inhibitors (e.g., ketoconazole, itraconazole, miconazole, nefazodone ritonavir).
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
Administration advice: